Trials / Withdrawn
WithdrawnNCT01491659
A Study to Evaluate the Effect and Safety of Idoform Plus on Bowel Side Effects in Healthy Subjects Treated With Amoxicillin/ Clavulanate
A Randomised, Double-blind, Placebo-controlled Study to Evaluate the Effect and Safety of Idoform Plus on Bowel Side Effects in Healthy Subjects Treated With Amoxicillin/ Clavulanate
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
It is hypothesized that Idoform plus will recuce the occurence of gastrointestinal side effects related to the use of antibiotics
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Idoform Plus | orally once daily |
| DIETARY_SUPPLEMENT | Placebo | orally once daily |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2011-12-14
- Last updated
- 2013-09-24
Source: ClinicalTrials.gov record NCT01491659. Inclusion in this directory is not an endorsement.